PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Radiopharmaceuticals and Contrast Media - Frost & Sullivan Predicts Market Growth in Europe - Although restrained by price sensitivity and reimbursement policies, the European market continues to grow for the foreseeable future - MedicalImaging.Frost.com
Radiopharmaceuticals and Contrast Media - Frost & Sullivan Predicts Market Growth in Europe

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/11/06 - Although restrained by price sensitivity and reimbursement policies, the European market continues to grow for the foreseeable future - MedicalImaging.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In many European countries, the distribution of contrasting agents is mainly through public tenders. Due to these tender systems, the average price of contrasting agents is reducing at the rate of 4% to 9% per annum in some regions.

Although the volume of contrasting agents used is increasing, the market is not able to grow at a very high rate, due to price erosion and restricted revenue per procedure. In the case of radiopharmaceuticals, although there is a rise in the relative number of vials being sold, there is not a big difference in the overall revenue generated, due to falling prices.

New analysis from Frost & Sullivan, Analysis of the European Radiopharmaceuticals and Contrast Media Market, (medicalimaging.frost.com), finds that the market earned revenues of $1.39 billion in 2011 and estimates this to reach $1.69 billion in 2017. The research covers contrast media used with X-ray, CT, MRI.

As growth of the contrast media market in X-ray and CT applications has attained maturity, revenue growth is accounted mainly to growth in the MRI contrast and ultrasound contrast segments.

"The increase in aged demographic would have an indirect impact on the contrast media market, as they would lead to a greater number of medical procedures and thus to a greater use of contrast media. This is one of the most important driving factors for this market," notes Frost & Sullivan Program Manager Sujith Eramangalath.

On the other hand, the usage expansion of nuclear medicine in other fields besides oncology, along with a large number of patients diagnosed with these conditions, is driving the radiopharmaceuticals market.

However, the radiopharmaceuticals market in Europe is highly regulated in terms of reimbursement and utilization.

"Many European countries have strict reimbursement policies regarding radioactive agents", adds Eramangalath. "This is a key issue that affects the growth of this market, as the introduction and the pricing of the agent are decided by the healthcare authorities. Considering the high amount of capital involved in the development of radiopharmaceuticals, lack of reimbursement causes dissatisfaction among manufacturers, and in turn among investors."

In addition, radiopharmaceuticals have a short half-life period, and need to be used before their half-life period, as they lose half of their radioactivity within this duration. Transport and logistics of radioactive material is also a major restraint. Transport agencies need to acquire specific certifications and take precautions for radiopharmaceuticals, and only a selected few transport agencies have the proper resources for transporting and handling such products.

"It is therefore necessary that end users are educated by companies about effectiveness, safety measures, and overall developments in imaging procedures", concludes Eramangalath. "This is likely to help in brand building and ensuring customer loyalty, apart from providing competitive advantages over other participants. It is also recommended that companies collaborate with academic institutions and training facilities to increase awareness about nuclear medicine among the medical fraternity."

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi[.]frost.com.

Analysis of the European Radiopharmaceuticals and Contrast Media Market is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: European Markets for Molecular Imaging, European Market for Computed Tomography. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Radiopharmaceuticals and Contrast Media - Frost & Sullivan Predicts Market Growth in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Anna Zanchi 
+39 02 46514819 anna.zanchi[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan
GE Healthcare Expands MRI Contrast Media Product Range in Europe with Launch of Macrocyclic Agent Clariscan
Sparta Systems Launches Product Registration Tracking for 123Compliance Cloud QMS
Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market
ZOLL Expands the Rescuer Experience at EMS Today
Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)